Search details
1.
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
EBioMedicine
; 98: 104878, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38016322
Results
1 -
1
de 1
1
Next >
>>